TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed December 8, 1978
TCL Archive New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial September 24, 2010
TCL Archive Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor. February 4, 2000